vs
HOME BANCSHARES INC（HOMB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
HOME BANCSHARES INC的季度营收约是REPLIGEN CORP的1.4倍（$282.1M vs $197.9M），HOME BANCSHARES INC净利率更高（41.9% vs 6.7%，领先35.2%），REPLIGEN CORP同比增速更快（13.6% vs 9.2%），HOME BANCSHARES INC自由现金流更多（$377.0M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.0%）
Home BancShares Inc是以Centennial Bank为运营品牌的银行控股企业，总部位于美国阿肯色州康威市，属于美国大型银行机构，目前在阿肯色、阿拉巴马、佛罗里达、得克萨斯四州及纽约市共设有222家营业网点。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HOMB vs RGEN — 直观对比
营收规模更大
HOMB
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出4.5%
9.2%
净利率更高
HOMB
高出35.2%
6.7%
自由现金流更多
HOMB
多$359.5M
$17.6M
两年增速更快
RGEN
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $282.1M | $197.9M |
| 净利润 | $118.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 54.4% | 9.0% |
| 净利率 | 41.9% | 6.7% |
| 营收同比 | 9.2% | 13.6% |
| 净利润同比 | 17.6% | 143.9% |
| 每股收益（稀释后） | $0.60 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOMBRGEN
| Q4 25 | $282.1M | $197.9M | ||
| Q3 25 | $277.7M | $188.8M | ||
| Q2 25 | $271.0M | $182.4M | ||
| Q1 25 | $260.1M | $169.2M | ||
| Q4 24 | $258.4M | $174.1M | ||
| Q3 24 | $258.0M | $154.9M | ||
| Q2 24 | $254.6M | $154.1M | ||
| Q1 24 | $246.4M | $151.3M |
净利润HOMBRGEN
| Q4 25 | $118.2M | $13.3M | ||
| Q3 25 | $123.6M | $14.9M | ||
| Q2 25 | $118.4M | $14.9M | ||
| Q1 25 | $115.2M | $5.8M | ||
| Q4 24 | $100.6M | $-30.3M | ||
| Q3 24 | $100.0M | $-654.0K | ||
| Q2 24 | $101.5M | $3.3M | ||
| Q1 24 | $100.1M | $2.1M |
毛利率HOMBRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率HOMBRGEN
| Q4 25 | 54.4% | 9.0% | ||
| Q3 25 | 57.4% | 8.9% | ||
| Q2 25 | 56.1% | 7.6% | ||
| Q1 25 | 56.6% | 3.9% | ||
| Q4 24 | 50.1% | -17.7% | ||
| Q3 24 | 50.0% | -5.1% | ||
| Q2 24 | 52.4% | 1.0% | ||
| Q1 24 | 52.9% | 1.3% |
净利率HOMBRGEN
| Q4 25 | 41.9% | 6.7% | ||
| Q3 25 | 44.5% | 7.9% | ||
| Q2 25 | 43.7% | 8.2% | ||
| Q1 25 | 44.3% | 3.4% | ||
| Q4 24 | 38.9% | -17.4% | ||
| Q3 24 | 38.8% | -0.4% | ||
| Q2 24 | 39.9% | 2.2% | ||
| Q1 24 | 40.6% | 1.4% |
每股收益（稀释后）HOMBRGEN
| Q4 25 | $0.60 | $0.24 | ||
| Q3 25 | $0.63 | $0.26 | ||
| Q2 25 | $0.60 | $0.26 | ||
| Q1 25 | $0.58 | $0.10 | ||
| Q4 24 | $0.50 | $-0.55 | ||
| Q3 24 | $0.50 | $-0.01 | ||
| Q2 24 | $0.51 | $0.06 | ||
| Q1 24 | $0.50 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $667.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $4.3B | $2.1B |
| 总资产 | $22.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HOMBRGEN
| Q4 25 | $667.3M | $767.6M | ||
| Q3 25 | $800.9M | $748.7M | ||
| Q2 25 | $1.1B | $708.9M | ||
| Q1 25 | $1.3B | $697.2M | ||
| Q4 24 | $910.3M | $757.4M | ||
| Q3 24 | $1.0B | $784.0M | ||
| Q2 24 | $1.1B | $809.1M | ||
| Q1 24 | $1.2B | $780.6M |
总债务HOMBRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益HOMBRGEN
| Q4 25 | $4.3B | $2.1B | ||
| Q3 25 | $4.2B | $2.1B | ||
| Q2 25 | $4.1B | $2.1B | ||
| Q1 25 | $4.0B | $2.0B | ||
| Q4 24 | $4.0B | $2.0B | ||
| Q3 24 | $4.0B | $2.0B | ||
| Q2 24 | $3.9B | $2.0B | ||
| Q1 24 | $3.8B | $2.0B |
总资产HOMBRGEN
| Q4 25 | $22.9B | $2.9B | ||
| Q3 25 | $22.7B | $2.9B | ||
| Q2 25 | $22.9B | $2.9B | ||
| Q1 25 | $23.0B | $2.9B | ||
| Q4 24 | $22.5B | $2.8B | ||
| Q3 24 | $22.8B | $2.8B | ||
| Q2 24 | $22.9B | $2.9B | ||
| Q1 24 | $22.8B | $2.8B |
负债/权益比HOMBRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $399.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $377.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 133.7% | 8.9% |
| 资本支出强度资本支出/营收 | 7.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 3.38× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $669.8M | $93.9M |
8季度趋势，按日历期对齐
经营现金流HOMBRGEN
| Q4 25 | $399.3M | $25.7M | ||
| Q3 25 | $115.2M | $48.1M | ||
| Q2 25 | $78.4M | $28.6M | ||
| Q1 25 | $117.0M | $15.0M | ||
| Q4 24 | $460.6M | $39.2M | ||
| Q3 24 | $128.6M | $49.3M | ||
| Q2 24 | $109.4M | $42.2M | ||
| Q1 24 | $147.5M | $44.7M |
自由现金流HOMBRGEN
| Q4 25 | $377.0M | $17.6M | ||
| Q3 25 | $112.2M | $43.4M | ||
| Q2 25 | $70.4M | $21.5M | ||
| Q1 25 | $110.1M | $11.4M | ||
| Q4 24 | $422.1M | $33.6M | ||
| Q3 24 | $116.2M | $42.3M | ||
| Q2 24 | $99.2M | $37.4M | ||
| Q1 24 | $145.9M | $36.4M |
自由现金流率HOMBRGEN
| Q4 25 | 133.7% | 8.9% | ||
| Q3 25 | 40.4% | 23.0% | ||
| Q2 25 | 26.0% | 11.8% | ||
| Q1 25 | 42.3% | 6.8% | ||
| Q4 24 | 163.4% | 19.3% | ||
| Q3 24 | 45.1% | 27.3% | ||
| Q2 24 | 38.9% | 24.3% | ||
| Q1 24 | 59.2% | 24.0% |
资本支出强度HOMBRGEN
| Q4 25 | 7.9% | 4.1% | ||
| Q3 25 | 1.0% | 2.5% | ||
| Q2 25 | 3.0% | 3.9% | ||
| Q1 25 | 2.6% | 2.1% | ||
| Q4 24 | 14.9% | 3.2% | ||
| Q3 24 | 4.8% | 4.5% | ||
| Q2 24 | 4.0% | 3.1% | ||
| Q1 24 | 0.7% | 5.5% |
现金转化率HOMBRGEN
| Q4 25 | 3.38× | 1.93× | ||
| Q3 25 | 0.93× | 3.23× | ||
| Q2 25 | 0.66× | 1.92× | ||
| Q1 25 | 1.02× | 2.57× | ||
| Q4 24 | 4.58× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.08× | 12.70× | ||
| Q1 24 | 1.47× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
